Trial Profile
A Phase 1/2a Randomized, Investigator-masked, Placebo- and Active-controlled, Dose-ranging Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 15 Apr 2014
Price :
$35
*
At a glance
- Drugs ATS 907 (Primary) ; Latanoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Altheos
- 15 Apr 2014 New trial record